Judith Fraser

993 total citations
11 papers, 70 citations indexed

About

Judith Fraser is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Judith Fraser has authored 11 papers receiving a total of 70 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Judith Fraser's work include Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Judith Fraser is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Judith Fraser collaborates with scholars based in United Kingdom, Finland and Sweden. Judith Fraser's co-authors include Nicola Steele, Sean Hopkins, Susan Dent, George Dranitsaris, Nadine Graham, Roberto D’Amico, David Cameron, Sadananda B Naik, Julie Dunn and Valentina Guarneri and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and JAMA Network Open.

In The Last Decade

Judith Fraser

7 papers receiving 64 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith Fraser United Kingdom	5	54	21	15	11	9	11	70
Béla Pikó Hungary	5	59 1.1×	22 1.0×	19 1.3×	3 0.3×	9 1.0×	20	89
Roberto Di Cicilia Italy	5	32 0.6×	18 0.9×	22 1.5×	5 0.5×	4 0.4×	14	63
M. Debled France	6	57 1.1×	50 2.4×	15 1.0×	18 1.6×	2 0.2×	16	85
B. Valenza France	6	67 1.2×	31 1.5×	34 2.3×	4 0.4×	6 0.7×	10	91
Francis Aitpillah Ghana	6	98 1.8×	58 2.8×	14 0.9×	22 2.0×	6 0.7×	10	139
P. Dalivoust France	3	46 0.9×	15 0.7×	16 1.1×	3 0.3×	6 0.7×	5	61
A. Kohls Germany	6	74 1.4×	62 3.0×	18 1.2×	9 0.8×	2 0.2×	13	104
Miranda Hughes United States	2	81 1.5×	8 0.4×	20 1.3×	3 0.3×	26 2.9×	3	113
Yiu-Keung Lau United States	4	29 0.5×	9 0.4×	20 1.3×	6 0.5×	1 0.1×	10	53
Angelo Fedele Scinto Italy	4	49 0.9×	11 0.5×	41 2.7×	4 0.4×	6 0.7×	4	67

Countries citing papers authored by Judith Fraser

Since Specialization

Citations

This map shows the geographic impact of Judith Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Fraser more than expected).

Fields of papers citing papers by Judith Fraser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Fraser. The network helps show where Judith Fraser may publish in the future.

Co-authorship network of co-authors of Judith Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Fraser. A scholar is included among the top collaborators of Judith Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Fraser. Judith Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Joensuu, Heikki, Judith Fraser, Hans Wildiers, et al.. (2024). Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer. JAMA Network Open. 7(8). e2429772–e2429772.

Cheng, Angela, Shannon Frank, K. H. Baines, et al.. (2023). 231P Trastuzumab deruxtecan for the treatment of metastatic breast cancer in the UK: Real-world data. ESMO Open. 8(1). 101419–101419. 1 indexed citations

Earl, Helena, Louise Hiller, Julie Dunn, et al.. (2021). LBA11 Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer. Annals of Oncology. 32. S1283–S1283. 14 indexed citations

Papadopoulou, Rodanthi, Ben Nichols, Judith Fraser, et al.. (2020). Gut microbial short chain fatty acids are associated with pathological complete response (pCR) after neoadjuvant chemotherapy for breast cancer. European Journal of Cancer. 138. S20–S20. 1 indexed citations

Sassarini, Jenifer, et al.. (2018). Managing vulvovaginal atrophy after breast cancer. Post Reproductive Health. 24(4). 163–165. 7 indexed citations

Dent, Susan, et al.. (2013). Clinical Outcomes of Women with Metastatic Breast Cancer Treated with Nab-Paclitaxel: Experience from a Single Academic Cancer Centre. Current Oncology. 20(1). 24–29. 11 indexed citations

Fraser, Judith, et al.. (2010). Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population of node positive breast cancer patients compared with PACS-01 trial group. European Journal of Cancer. 47(2). 215–220. 22 indexed citations

Scott, Lucy, Judith Fraser, & Jim Cassidy. (2003). Emerging drugs in colorectal cancer. Expert Opinion on Emerging Drugs. 8(1). 193–202. 3 indexed citations

Scott, Lucy, Judith Fraser, & Jim Cassidy. (2003). Emerging drugs in colorectal cancer. Expert Opinion on Emerging Drugs. 8(1). 193–202. 1 indexed citations

10.

Fraser, Judith, et al.. (2002). Head louse and other common infections in schools: head teachers' use of an information pack.. PubMed. 12(3). 76–9.

11.

Bono, Johann S. de, et al.. (2000). Metastatic extragonadal seminoma associated with cardiac transplantation. Annals of Oncology. 11(6). 749–752. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact